INTERREG V-A Italia – Malta 2014-2020 MEDIWARN Virtual Biosensor
for Medical Warning Precursors

Homepage 5

MEDIWARN
ABSTRACT

COMPLETION OF THE PROJECT 65%

The continuous monitoring and measurement of vital functions is extremely important in order to ensure early and rapid action in critical patients, who could have a progressive clinical deterioration.

At this time, the instrument of control used by health workers is the EWS. It is based on the collection of physiological parameters to be included in a scale score that allows a rapid evaluation of patient status. However, it is very often necessary to detect the alterations preceding this stage, predicting critical condition for the patient.

However, it is very often necessary to detect the alterations preceding this stage, predicting critical condition for the patient.

To overcome this limit, the project will develop a Virtual Biosensor that, by making use of sensors already certified for the measurement of vital parameters, implements a logic able to predict possible patient's clinical degenerations. The basic principle is to collect the physiological parameters as the input of a mathematical model that provides an output related to the patient’s state, by using a data set (rules) established with the medical team.

In this context, the cross border approach promotes an extended point of view based on the experience of two territories that use a different organizational and business model within healthcare facilities. This provides greater robustness to the method that will be developed and the possibility to extend it more easily to other Countries operating with different models. As a result, the joint collaboration of the medical team and clinical validation of the biosensor in the Italian and Maltese health facilities are required.

The latter will benefit from better management of medical and nursing staff with a direct impact on the quality of service provided to patients. Furthermore, companies operating in the electromedical sector will exploit the innovation and technologies developed in the project by getting economic and employment benefits.

VIDEO MEDIWARN

Prof. Rosario Sinatra

Scientific Project Manager

PARTNER OF
MEDIWARN

Lead Partner

Project Partner n.2

Project Partner n.3

Project presentation

MEDIWARN
Virtual Biosensor for Medical Warning Precursors

INTERREG V-A Italia – Malta 2014-2020

Asse prioritario I, Obiettivo Specifico 1.1 Codice C1-1.1-13

Increase the activity of innovation and research to improve the quality of life and the use of cultural heritage

INVESTMENT PRIORITY

Promote business investment in R&I by developing links and synergies between businesses

  • START DATE: 30.05.2018
  • END DATE: 29.11.2020
  • DURATION: 30 MONTHS
  • PRIORITY AXIS OF THE PROGRAM: AXIS 1
  1. Technology takeover by companies in the electro-medical sector
  2. Strengthening the skills of medical/nursing staff
  3. Benefit of patient trials

Sources of co-financing of the project - distribution among the partners

  • Università degli Studi di Catania
  • Università di Malta
  • Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele
  • € 619.920,00

  • € 482.436,80
  • € 520.166,65

SOME
DATA

1722523

TOTAL BUDGET OF THE PROJECT IN €

15

TEAM

39

DURATION IN MONTHS OF THE PROJECT

DO YOU WANT TO RECEIVE UPDATES?

SIGN UP TO OUR
NEWSLETTER

LATEST NEWS

en_GBEnglish
it_ITItalian en_GBEnglish